Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 49, 2019 - Issue 6
504
Views
20
CrossRef citations to date
0
Altmetric
General Xenobiochemistry

A metabolomic perspective of pazopanib-induced acute hepatotoxicity in mice

, , , , , , & show all
Pages 655-670 | Received 16 May 2018, Accepted 11 Jun 2018, Published online: 23 Jul 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Wan Peng, Man-Yun Dai, Li-Juan Bao, Wei-Feng Zhu & Fei Li. (2021) FXR activation prevents liver injury induced by Tripterygium wilfordii preparations. Xenobiotica 51:6, pages 716-727.
Read now
Yao Xiao, Yi-Kun Wang, Xue-Rong Xiao, Qi Zhao, Jian-Feng Huang, Wei-Feng Zhu & Fei Li. (2020) Metabolic profiling of coumarins by the combination of UPLC-MS-based metabolomics and multiple mass defect filter. Xenobiotica 50:9, pages 1076-1089.
Read now
S. Cyrus Khojasteh, James P. Driscoll, Klarissa D. Jackson, Grover P. Miller, Kaushik Mitra, Ivonne M. C. M Rietjens & Donglu Zhang. (2020) Novel advances in biotransformation and bioactivation research—2019 year in review. Drug Metabolism Reviews 52:3, pages 333-365.
Read now
Qiang Shi, Xi Yang, Lijun Ren & William B. Mattes. (2020) Recent advances in understanding the hepatotoxicity associated with protein kinase inhibitors. Expert Opinion on Drug Metabolism & Toxicology 16:3, pages 217-226.
Read now

Articles from other publishers (16)

K. Westerdijk, S. D. Krens, N. Steeghs, W. T. A. van der Graaf, E. T. T. L. Tjwa, H. Westdorp, I. M. E. Desar & N. P. van Erp. (2023) Real-world data on the management of pazopanib-induced liver toxicity in routine care of renal cell cancer and soft tissue sarcoma patients. Cancer Chemotherapy and Pharmacology 93:4, pages 353-364.
Crossref
Miaomiao Tang, Zhanxuan E. Wu & Fei Li. (2024) Integrating network pharmacology and drug side-effect data to explore mechanism of liver injury-induced by tyrosine kinase inhibitors. Computers in Biology and Medicine 170, pages 108040.
Crossref
Guillermo Quintás, José V. Castell & Marta Moreno-Torres. (2023) The assessment of the potential hepatotoxicity of new drugs by in vitro metabolomics. Frontiers in Pharmacology 14.
Crossref
Qi Zhao, Man-Yun Dai, Ruo-Yue Huang, Jing-Yi Duan, Ting Zhang, Wei-Min Bao, Jing-Yi Zhang, Shao-Qiang Gui, Shu-Min Xia, Cong-Ting Dai, Ying-Mei Tang, Frank J. Gonzalez & Fei Li. (2023) Parabacteroides distasonis ameliorates hepatic fibrosis potentially via modulating intestinal bile acid metabolism and hepatocyte pyroptosis in male mice. Nature Communications 14:1.
Crossref
Hana Studentova, Jindriska Volakova, Martina Spisarova, Anezka Zemankova, Kvetoslava Aiglova, Tomas Szotkowski & Bohuslav Melichar. (2022) Severe tyrosine-kinase inhibitor induced liver injury in metastatic renal cell carcinoma patients: two case reports assessed for causality using the updated RUCAM and review of the literature. BMC Gastroenterology 22:1.
Crossref
Maud Maillard, Cécile Arellano, Christelle Vachoux, Christine Chevreau, Nicolas J. Cabaton, Frédéric Pont, Nathalie Saint-Laurent, Thierry Lafont, Etienne Chatelut & Fabienne Thomas. (2022) Biological Role of Pazopanib and Sunitinib Aldehyde Derivatives in Drug-Induced Liver Injury. Metabolites 12:9, pages 852.
Crossref
Alf Claesson & Kevin Parkes. (2022) Non-innocuous Consequences of Metabolic Oxidation of Alkyls on Arenes. Journal of Medicinal Chemistry 65:17, pages 11433-11453.
Crossref
Qi Zhao, Zhanxuan E. Wu, Bin Li & Fei Li. (2022) Recent advances in metabolism and toxicity of tyrosine kinase inhibitors. Pharmacology & Therapeutics 237, pages 108256.
Crossref
Filipa Amaro, Carolina Pisoeiro, Maria João Valente, Maria de Lourdes Bastos, Paula Guedes de Pinho, Márcia Carvalho & Joana Pinto. (2022) Sunitinib versus Pazopanib Dilemma in Renal Cell Carcinoma: New Insights into the In Vitro Metabolic Impact, Efficacy, and Safety. International Journal of Molecular Sciences 23:17, pages 9898.
Crossref
Rui Li, Yun-Li Zhao, Feng Qin, Yang Zhao, Xue-Rong Xiao, Wei-Yi Cao, Mao-Rong Fan, Shu-Ge Wang, Yi Wu, Bing Wang, Chang-Zheng Fan, Zhong-Ning Guo, Qiao-Ning Yang, Wan-Tong Zhang, Xin-Gang Li, Fei Li, Xiao-Dong Luo & Rui Gao. (2022) The clinical population pharmacokinetics, metabolomics and therapeutic analysis of alkaloids from Alstonia scholaris leaves in acute bronchitis patients. Phytomedicine 98, pages 153979.
Crossref
Baran Akagunduz, Muhammet Ozer, Fatih Ozcıcek, Ali Veysel Kara, Sahin Lacın, Mustafa Özkaraca, Abdulkadir Çoban, Bahadır Suleyman, Renad Mammadov & Halis Suleyman. (2021) Protective effects of taxifolin on pazopanib-induced liver toxicity: an experimental rat model. Experimental Animals 70:2, pages 169-176.
Crossref
Xuerong Xiao, Ting Zhang, Jianfeng Huang, Qi Zhao & Fei Li. (2020) Effect of CYP3A4 on liver injury induced by triptolide. Biomedical Chromatography 34:8.
Crossref
Zi-Meng Zhou, Yi-Kun Wang, Dong-Mei Yan, Jian-He Fang, Xue-Rong Xiao, Ting Zhang, Yan Cheng, Kang-Ping Xu & Fei Li. (2020) Metabolic profiling of tyrosine kinase inhibitor nintedanib using metabolomics. Journal of Pharmaceutical and Biomedical Analysis 180, pages 113045.
Crossref
Marie-Noëlle Paludetto, Jean-Luc Stigliani, Anne Robert, Vania Bernardes-Génisson, Etienne Chatelut, Florent Puisset & Cécile Arellano. (2019) Involvement of Pazopanib and Sunitinib Aldehyde Reactive Metabolites in Toxicity and Drug–Drug Interactions in Vitro and in Patient Samples . Chemical Research in Toxicology 33:1, pages 181-190.
Crossref
Yi-Kun Wang, Xiao-Nan Yang, Xu Zhu, Xue-Rong Xiao, Xiu-Wei Yang, Hong-Bo Qin, Frank J. Gonzalez & Fei Li. (2019) Role of Metabolic Activation in Elemicin-Induced Cellular Toxicity. Journal of Agricultural and Food Chemistry 67:29, pages 8243-8252.
Crossref
Anne-Laure Clairet, Marie Boiteux-Jurain, Elsa Curtit, Marie Jeannin, Blandine Gérard, Virginie Nerich & Samuel Limat. (2019) Interaction between phytotherapy and oral anticancer agents: prospective study and literature review. Medical Oncology 36:5.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.